Market Overview:
The global acute kidney injury treatment and management market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market is segmented by type, application, and region. The type segment is further divided into prerenal acute kidney injury, intrinsic renal acute kidney injury, and postrenal acute kidney injury. The application segment is divided into hospitals, ambulatory surgical centers (ASCs), and others. The regions are North America, Latin America, Europe Asia Pacific (APAC), and Middle East & Africa (MEA). The growth of the global acute kidney injury treatment and management market can be attributed to the increasing incidence of chronic diseases such as diabetes mellitus (DM) and hypertension; rising geriatric population; growing awareness about early diagnosis of AKI; technological advancements in the field of renal replacement therapies such as peritoneal dialysis (PD) machines; increasing number of patients undergoing surgeries annually; rising demand for home-based dialysis services due to their cost-effectiveness over hospital-based dialysis services; government initiatives for improving healthcare infrastructure in developing countries ;and growing investments by private players in this market . However ,the high cost associated with renal replacement therapies may restrain the growth of this market during the forecast period .
Product Definition:
Acute kidney injury (AKI) is a sudden, potentially reversible decline in renal function. AKI may result from many causes, including prerenal azotemia, intrinsic renal disease, and drug toxicity or idiosyncratic reactions. Treatment of AKI focuses on identification and correction of the underlying cause.
Prerenal Acute Kidney Injury:
Prerenal acute kidney injury is a type of kidney damage that occurs before the urine has time to reach the bladder. It can be caused by high blood pressure, diabetes, drugs, and other toxins. The main causes of AKI are hypertension (high blood pressure), diabetes mellitus and renal dysfunction associated with glomerulonephritis or renal failure. AKI accounts for approximately 10% - 15% of all hospital admissions in patients suffering from acute kidney injury (AKI).
Intrinsic Renal Acute Kidney Injury:
Intrinsic renal acute kidney injury is an uncommon but life-threatening complication of COVID-19. It accounts for around 10% of all the cases where patients have developed Acute Kidney Injury (AKI) during the pandemic. The condition has been reported in both adults and children, with a peak age of 60 years.
Application Insights:
The others segment held the largest share of the global acute kidney injury treatment & management market in 2017. This segment includes emergency rooms, hospitals, and outpatient clinics. Outpatient clinics held a larger share as compared to hospitals as they are more convenient for patients with acute kidney injuries (AKI) to access care. However, this may increase healthcare costs as these patients require higher levels of monitoring and intensive care unit (ICU) stay due to their risk factors associated with AKI such as age greater than 60 years or history of diabetes or hypertension.
Hospitals are considered the most effective settings for treating AKI due to advanced medical equipment available there along with highly skilled personnel who can manage complicated cases effectively.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and favorable reimbursement policies. The Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing healthcare expenditure and rising awareness about acute kidney injury treatment & management in emerging countries such as China & India. Moreover, improving healthcare infrastructure is also anticipated to drive market growth during the forecast period.
Some of key companies operating in this space are Fresenius Medical Care; Johnson & Johnson Services Inc.; UHG International N.V.; Fresenius Kabi; Renin Technologies Ltd.; Bio-Rad Laboratories; Abbott Laboratories; American Diagnostic Corporation (ADC); Beckman Coulter Inc.
Growth Factors:
- Increasing incidence of acute kidney injury (AKI) due to various reasons such as diabetes, hypertension, and sepsis is expected to drive the growth of the market.
- Rising awareness about early diagnosis and treatment of AKI is anticipated to propel the demand for acute kidney injury treatment & management products and services.
- Technological advancements in renal replacement therapies are likely to provide lucrative opportunities for market players over the forecast period.
- Growing number of patients suffering from chronic kidney diseases (CKD) is projected to fuel the demand for acute kidney injury treatments & management products and services in near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Acute Kidney Injury Treatment & Management Market Research Report
By Type
Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury, Postrenal Acute Kidney Injury
By Application
Hospitals, Ambulatory Surgical Centers, Others
By Companies
B. Braun Melsungen AG, Baxter International, Inc., Asahi Kasei Medical Co., Ltd, Angion Biomedica Corp, AM-Pharma, Quark Pharmaceuticals, Inc, Fresenius Medical Care AG & Co. KGaA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
146
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Acute Kidney Injury Treatment & Management Market Report Segments:
The global Acute Kidney Injury Treatment & Management market is segmented on the basis of:
Types
Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury, Postrenal Acute Kidney Injury
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- B. Braun Melsungen AG
- Baxter International, Inc.
- Asahi Kasei Medical Co., Ltd
- Angion Biomedica Corp
- AM-Pharma
- Quark Pharmaceuticals, Inc
- Fresenius Medical Care AG & Co. KGaA
Highlights of The Acute Kidney Injury Treatment & Management Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prerenal Acute Kidney Injury
- Intrinsic Renal Acute Kidney Injury
- Postrenal Acute Kidney Injury
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Acute Kidney Injury Treatment & Management Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Acute kidney injury (AKI) is a medical emergency that can occur when the kidneys are damaged. AKI can lead to serious health problems if not treated quickly. Treatment for AKI includes providing fluids and electrolytes, antibiotics if needed, and pain relief. Patients may also need blood transfusions and surgery to restore function to their kidneys.
Some of the major players in the acute kidney injury treatment & management market are B. Braun Melsungen AG, Baxter International, Inc., Asahi Kasei Medical Co., Ltd, Angion Biomedica Corp, AM-Pharma, Quark Pharmaceuticals, Inc, Fresenius Medical Care AG & Co. KGaA.
The acute kidney injury treatment & management market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Acute Kidney Injury Treatment & Management Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Acute Kidney Injury Treatment & Management Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Acute Kidney Injury Treatment & Management Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Acute Kidney Injury Treatment & Management Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Acute Kidney Injury Treatment & Management Market Size & Forecast, 2018-2028
4.5.1 Acute Kidney Injury Treatment & Management Market Size and Y-o-Y Growth
4.5.2 Acute Kidney Injury Treatment & Management Market Absolute $ Opportunity
Chapter 5 Global Acute Kidney Injury Treatment & Management Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Acute Kidney Injury Treatment & Management Market Size Forecast by Type
5.2.1 Prerenal Acute Kidney Injury
5.2.2 Intrinsic Renal Acute Kidney Injury
5.2.3 Postrenal Acute Kidney Injury
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Acute Kidney Injury Treatment & Management Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Acute Kidney Injury Treatment & Management Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Acute Kidney Injury Treatment & Management Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Acute Kidney Injury Treatment & Management Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Acute Kidney Injury Treatment & Management Analysis and Forecast
9.1 Introduction
9.2 North America Acute Kidney Injury Treatment & Management Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Acute Kidney Injury Treatment & Management Market Size Forecast by Type
9.6.1 Prerenal Acute Kidney Injury
9.6.2 Intrinsic Renal Acute Kidney Injury
9.6.3 Postrenal Acute Kidney Injury
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Acute Kidney Injury Treatment & Management Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Acute Kidney Injury Treatment & Management Analysis and Forecast
10.1 Introduction
10.2 Europe Acute Kidney Injury Treatment & Management Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Acute Kidney Injury Treatment & Management Market Size Forecast by Type
10.6.1 Prerenal Acute Kidney Injury
10.6.2 Intrinsic Renal Acute Kidney Injury
10.6.3 Postrenal Acute Kidney Injury
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Acute Kidney Injury Treatment & Management Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Acute Kidney Injury Treatment & Management Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Acute Kidney Injury Treatment & Management Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Acute Kidney Injury Treatment & Management Market Size Forecast by Type
11.6.1 Prerenal Acute Kidney Injury
11.6.2 Intrinsic Renal Acute Kidney Injury
11.6.3 Postrenal Acute Kidney Injury
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Acute Kidney Injury Treatment & Management Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Acute Kidney Injury Treatment & Management Analysis and Forecast
12.1 Introduction
12.2 Latin America Acute Kidney Injury Treatment & Management Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Acute Kidney Injury Treatment & Management Market Size Forecast by Type
12.6.1 Prerenal Acute Kidney Injury
12.6.2 Intrinsic Renal Acute Kidney Injury
12.6.3 Postrenal Acute Kidney Injury
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Acute Kidney Injury Treatment & Management Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Acute Kidney Injury Treatment & Management Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Acute Kidney Injury Treatment & Management Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Acute Kidney Injury Treatment & Management Market Size Forecast by Type
13.6.1 Prerenal Acute Kidney Injury
13.6.2 Intrinsic Renal Acute Kidney Injury
13.6.3 Postrenal Acute Kidney Injury
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Acute Kidney Injury Treatment & Management Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Acute Kidney Injury Treatment & Management Market: Competitive Dashboard
14.2 Global Acute Kidney Injury Treatment & Management Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 B. Braun Melsungen AG
14.3.2 Baxter International, Inc.
14.3.3 Asahi Kasei Medical Co., Ltd
14.3.4 Angion Biomedica Corp
14.3.5 AM-Pharma
14.3.6 Quark Pharmaceuticals, Inc
14.3.7 Fresenius Medical Care AG & Co. KGaA
